4.6 Article

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD

期刊

出版社

AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.03830318

关键词

chronic kidney disease; practice patterns; nephrology visits; variations; albuminuria; glomerular filtration rate; Angiotensin-Converting Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; creatinine; blood pressure; Veterans; Confidence Intervals; Kidney Function Tests; Renal Insufficiency; Chronic; diabetes mellitus; Hemoglobins; Angiotensin Receptor Antagonists; Albumins; Outcome Assessment (Health Care); Referral and Consultation

资金

  1. American Heart Association [14BGIA20460366]
  2. American Diabetes Association Clinical Science and Epidemiology award [1-14-CE-44]
  3. Houston Veterans Affairs Health Services Research and Development Center for Innovations [CIN13-413]

向作者/读者索取更多资源

Background and objectives Facility-level variation has been reported among veterans receiving care for various diseases. We studied the frequency and facility-level variations of guideline-recommended practices in patients with diabetes and CKD. Design, setting, participants, & measurements Patients with diabetes and concomitant CKD (eGFR 15-59 ml/min per 1.73 m(2), measured twice, 90 days apart) receiving care in 130 facilities across the Veterans Affairs Health Care System were included (n=281,223). We studied the proportions of patients (facility-level) receiving recommended core measures and facility-level variations of these study outcomes using median rate ratios, adjusting for various patient and provider-level factors. Median rate ratio quantifies the degree to which care may vary for similar patients receiving care at two randomly chosen facilities, with <1 being no variation and >1.2 as substantial variation between the facilities. Study outcomes included measurement of urine albumin-to-creatinine ratio/urine protein-to-creatinine ratio and blood hemoglobin concentration, prescription of statins and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, BP<140/90 mm Hg, and referral to a Veterans Affairs nephrologist (only for those with eGFR<30 ml/min per 1.73 m(2)). Results Among those with eGFR 30-59 ml/min per 1.73 m(2), proportion of patients receiving recommended core measures (median and interquartile range across facilities) were 37% (22%-47%) for urine albumin-to-creatinine ratio/urine protein-to-creatinine ratio, 74% (72%-79%) for hemoglobin measurement, 66% (62%-69%) for angiotensin-converting enzyme inhibitor/angiotensin receptor blocker prescription, 85% (74%-87%) for statin prescription, 47% (42%-53%) for achieving BP<140/90 mm Hg, and 13% (7%-16%) for meeting all outcome measures. Adjusted median rate ratios (95% confidence intervals) were 5.2 (4.1 to 6.4), 2.4 (2.1 to 2.6), 1.3 (1.2 to 1.3), 1.2 (1.2 to 1.3), 1.4 (1.3 to 1.4), and 4.1 (3.3 to 5.0), respectively. Median rate ratios were qualitatively similar in an analysis restricted to those with eGFR 15-29 ml/min per 1.73 m(2). Conclusions Among patients with diabetes and CKD, at facility-level, ordering of laboratory tests, and scheduling of nephrology referrals in eligible patients remains suboptimal, with substantial variations across facilities.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Optic neuropathy after COVID-19 vaccination: a report of two cases

Ayman G. Elnahry, Zainab B. Asal, Noreen Shaikh, Kate Dennett, Mai N. Abd Elmohsen, Gehad A. Elnahry, Azza Shehab, Michal Vytopil, Leila Ghaffari, Geetha K. Athappilly, David J. Ramsey

Summary: This report describes two cases of optic nerve pathology after COVID-19 vaccination and discusses the management implications for post-vaccination central nervous system (CNS) inflammation. The cases involve a 69-year-old woman and a 32-year-old woman who experienced optic nerve issues after receiving the Pfizer-BioNTech and AstraZeneca-Oxford vaccines, respectively. Both patients showed improvement and recovery following treatment.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2023)

Article Genetics & Heredity

Multimodal image alignment aids in the evaluation and monitoring of sector retinitis pigmentosa

James T. Kwan, David J. Ramsey

Summary: This study presents a semi-automated method of image alignment to monitor the progression of inherited retinal degenerations. The results show the case of a 22-year-old woman with inherited retinal degeneration, including the findings from fundus examination and multimodal imaging. The study highlights the utility of image registration and alignment in monitoring disease progression in IRDs.

OPHTHALMIC GENETICS (2023)

Article Ophthalmology

Visual recovery after unilateral optic nerve sheath fenestration for pseudotumor cerebri syndrome

Yi Ling Dai, David J. Ramsey, Geetha K. Athappilly, Susan M. Tucker

Summary: ONSF leads to rapid improvement in papilledema and steady recovery in VF in appropriately selected patients.

ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY (2023)

Article Biochemistry & Molecular Biology

Plasma proteins related to inflammatory diet predict future cognitive impairment

Michael R. R. Duggan, Lauren Butler, Zhongsheng Peng, Gulzar N. N. Daya, Abhay Moghekar, Yang An, Stephen R. R. Rapp, Kathleen M. M. Hayden, Aladdin H. H. Shadyab, Ginny Natale, Longjian Liu, Linda Snetselaar, Ruin Moaddel, Casey M. M. Rebholz, Kevin Sullivan, Christie M. M. Ballantyne, Susan M. M. Resnick, Luigi Ferrucci, Keenan A. A. Walker

Summary: Dysregulation of the immune system and inflammatory dietary patterns may increase the risk for cognitive decline. Proteomic assays of plasma samples identified a group of proteins linked to future cognitive impairment, as well as associations with dementia risk and biomarkers of Alzheimer's disease and neurodegeneration.

MOLECULAR PSYCHIATRY (2023)

Article Health Care Sciences & Services

Effectiveness and Financial Viability of Telehealth Physician Extenders for Re-Engagement of Patients with Diabetic Retinopathy

Rachel Munzar, Joseph A. A. Anaya, Claudia Lasalle, Shiyoung Roh, David J. J. Ramsey

Summary: The study aims to evaluate the effectiveness and financial implications of employing a telehealth physician extender program in re-engaging lost-to-follow-up patients with diabetic retinopathy (DR). Randomized patients were assigned to a recall intervention or standard operating procedure (SOP), and the intervention group demonstrated higher rates of appointment scheduling and adherence. The use of a telehealth physician extender improves patient re-engagement at a reasonable cost.

TELEMEDICINE AND E-HEALTH (2023)

Letter Cardiac & Cardiovascular Systems

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease

Salim S. S. Virani, David J. J. Ramsey, Dax Westerman, Mark K. K. Kuebeler, Liang Chen, Julia M. M. Akeroyd, Glenn T. T. Gobbel, Christie M. M. Ballantyne, Laura A. A. Petersen, Alexander Turchin, Michael E. E. Matheny

CIRCULATION (2023)

Letter Cardiac & Cardiovascular Systems

Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease

Yiyi Zhang, Jacqueline S. Dron, Brandon K. Bellows, Amit V. Khera, Junxiu Liu, Pallavi P. Balte, Elizabeth C. Oelsner, Sami Samir Amr, Matthew S. Lebo, Anna Nagy, Gina M. Peloso, Pradeep Natarajan, Jerome I. Rotter, Cristen Willer, Eric Boerwinkle, Christie M. Ballantyne, Pamela L. Lutsey, Myriam Fornage, Donald M. Lloyd-Jones, Lifang Hou, Bruce M. Psaty, Joshua C. Bis, James S. Floyd, Ramachandran S. Vasan, Nancy L. Heard-Costa, April P. Carson, Michael E. Hall, Stephen S. Rich, Xiuqing Guo, Dhruv S. Kazi, Sarah D. de Ferranti, Andrew E. Moran

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

Nicolas Girerd, Daniel Levy, Kevin Duarte, Joao Pedro Ferreira, Christie Ballantyne, Timothy Collier, Anne Pizard, Jens Bjoerkman, Javed Butler, Andrew Clark, John G. Cleland, Christian Delles, Javier Diez, Arantxa Gonzalez, Mark Hazebroek, Jennifer Ho, Anne-Cecile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A. Staessen, Job Verdonschot, Stephane Heymans, Patrick Rossignol, Faiez Zannad

Summary: This study identified protein biomarkers associated with new-onset heart failure in three independent cohorts. The inclusion of these biomarkers in addition to clinical risk factors improved the prediction of heart failure risk. The B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide were found to be particularly relevant in predicting heart failure.

CIRCULATION-HEART FAILURE (2023)

Article Endocrinology & Metabolism

Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study

Suzanne V. Arnold, James A. de Lemos, Luke Zheng, Robert S. Rosenson, Christie M. Ballantyne, Shushama Alam, Deepak L. Bhatt, Christopher P. Cannon, Mikhail Kosiborod, GOULD Investigators

Summary: The study aimed to examine the improvement in the use of optimal medical therapy (OMT) for patients with atherosclerotic cardiovascular disease (ASCVD) and diabetes. The study found that the use of secondary prevention in US patients with ASCVD and diabetes was suboptimal, with minimal improvement over time.

DIABETES OBESITY & METABOLISM (2023)

Article Pharmacology & Pharmacy

Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial

Paul M. Ridker, Lei Lei, Kausik K. Ray, Christie M. Ballantyne, Gary Bradwin, Nader Rifai

Summary: Bempedoic acid (BA) reduces hsCRP and LDL-C levels in patients with atherosclerotic disease and/or familial hypercholesterolemia. It also shows potential anti-inflammatory effects and has similar lipid-lowering and inflammation-inhibiting properties to statin therapy.

JOURNAL OF CLINICAL LIPIDOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study

Lena Mathews, Xiao Hu, Ning Ding, Junichi Ishigami, Mahmoud Al Rifai, Ron C. C. Hoogeveen, Josef Coresh, Christie M. M. Ballantyne, Elizabeth Selvin, Kunihiro Matsushita

Summary: A study on 9205 participants from the ARIC study found that higher levels of GDF15 protein were associated with bleeding events and improved the prediction of bleeding risk in individuals without cardiovascular disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry

Marina Cuchel, Paul C. Lee, Lisa C. Hudgins, P. Barton Duell, Zahid Ahmad, Seth J. Baum, MacRae F. Linton, Sarah D. de Ferranti, Christie M. Ballantyne, John A. Larry, Linda C. Hemphill, Iris Kindt, Samuel S. Gidding, Seth S. Martin, Patrick M. Moriarty, Paul P. Thompson, James A. Underberg, John R. Guyton, Rolf L. Andersen, David J. Whellan, Irwin Benuck, John P. Kane, Kelly Myers, William Howard, David Staszak, Allison Jamison, Mary C. Card, Mafalda Bourbon, Joana R. Chora, Daniel J. Rader, Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan

Summary: This study investigated the diagnosis and treatment of HoFH in the United States and found a low diagnosis rate and low treatment rate, highlighting the need for enhanced screening and treatment to reduce the burden of the disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT

Brian Olshansky, Deepak L. L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. A. Brinton, Terry A. A. Jacobson, Steven B. B. Ketchum, Ralph T. T. Doyle Jr, Rebecca A. A. Juliano, Lixia Jiao, Peter R. R. Kowey, James A. A. Reiffel, Jean-Claude Tardif, Christie M. M. Ballantyne, Mina K. K. Chung

Summary: In the REDUCE-IT study, icosapent ethyl (IPE) reduced cardiovascular events but was associated with increased atrial fibrillation/atrial flutter (AF) hospitalization. The study analyzed the relationships between IPE and outcomes in patients with or without prior AF and with or without in-study AF hospitalization. Overall, in-study AF hospitalization rates were higher in patients with prior AF, especially in those randomized to IPE. Serious bleeding rates also trended higher in these patients. However, patients with prior AF or in-study AF hospitalization showed consistent risk reductions in cardiovascular events with IPE.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Ophthalmology

Second eyes to develop neovascular age-related macular degeneration have fewer symptoms and better one-year visual outcomes

F. Sema Akkan Aydogmus, Oluchukwu Onwuka, Jackson Saddemi, Claudia C. Lasalle, David J. Ramsey

Summary: This study compared visual and anatomical outcomes for patients with sequential neovascular age-related macular degeneration (nAMD), both at diagnosis and one year after treatment. Results showed that second eyes had better visual acuity and smaller pigment epithelial detachment (PED) heights at diagnosis and at one year after treatment compared to first eyes. This may be due to earlier diagnosis enabled by monitoring.

BMC OPHTHALMOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events

Austin Deets, Parag H. Joshi, Alvin Chandra, Kavisha Singh, Amit Khera, Salim S. Virani, Christie M. Ballantyne, James D. Otvos, Robin P. F. Dullaart, Eke G. Gruppen, Margery A. Connelly, Colby Ayers, Ann Marie Navar, Ambarish Pandey, John T. Wilkins, Anand Rohatgi

Summary: This study aimed to assess the association between levels of specific size-based HDL subspecies and atherosclerotic cardiovascular disease, and investigate their role in risk prediction.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

暂无数据